Create your Personal Health Record and unlock support built around you

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects

How Long Will I Live With Small-Cell Lymphocytic Lymphoma?

Posted by
HealthTree image
HealthTree
Last updated and reviewed on: July 09, 2026

How Long Will I Live With Small-Cell Lymphocytic Lymphoma?

Small-Cell Lymphocytic Lymphoma (SLL) is a type of non-Hodgkins lymphoma that is typically slow-growing. The survival rate can vary widely depending on various factors such as the stage of the disease, the patient's overall health, age, and response to treatment. On average, the median survival rate for patients with SLL is about 10 years, but many patients live much longer. It's important to note that these are averages and individual prognosis can vary greatly.

What do statistics say about the life expectancy for someone with Small-Cell Lymphocytic Lymphoma?

According to the American Cancer Society, the 5-year survival rate estimates are:

  • Stage I SLL is about 82%.

  • Stage II SLL is about 75%.

  • Stage III SLL is about 63%

  • Stage IV SLL is about 43%.

However, these statistics are based on the stage at diagnosis and do not take into account individual patient characteristics and treatment responses. It's also important to remember that survival rates are estimates and are often based on previous outcomes of large numbers of people who had a specific cancer, but they can't predict what will happen in any individual's case.

What factors affect prognosis for Small-Cell Lymphocytic Lymphoma?

  • Stage of the disease: The stage of SLL at the time of diagnosis can significantly impact the prognosis. Early-stage disease (stage I or II) generally has a better prognosis than late-stage disease (stage III or IV).

  • Age and overall health: Younger patients and those in good overall health typically have a better prognosis.

  • Response to treatment: Patients who respond well to initial treatment often have a better prognosis.

  • Presence of symptoms: Patients who have symptoms at the time of diagnosis (such as weight loss, fever, and night sweats) may have a worse prognosis.

  • Cell characteristics: Certain cellular characteristics, such as a high proliferation (cell growth) rate or the presence of certain genetic mutations, can affect prognosis.

These factors can all influence the course of SLL and the patient's life expectancy. However, it's important to remember that each patient's situation is unique and these factors are just part of the overall picture. The treating oncologist or specialist is the best source of information about an individual's prognosis.

Having an SLL specialist on your team provides you with the best way of truly understanding your prognosis. Visit HealthTree's SLL Specialist Directory to find an SLL expert near you. You can also join HealthTree's social media platform, HealthTree Connect to meet other patients and learn what they've done personally to live longer with SLL. 

Related Content